Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Author:

Horwitz Steven,O'Connor Owen A,Pro Barbara,Illidge Tim,Fanale Michelle,Advani Ranjana,Bartlett Nancy L,Christensen Jacob Haaber,Morschhauser Franck,Domingo-Domenech Eva,Rossi Giuseppe,Kim Won Seog,Feldman Tatyana,Lennard Anne,Belada David,Illés Árpád,Tobinai Kensei,Tsukasaki Kunihiro,Yeh Su-Peng,Shustov Andrei,Hüttmann Andreas,Savage Kerry J,Yuen Sam,Iyer Swaminathan,Zinzani Pier Luigi,Hua Zhaowei,Little Meredith,Rao Shangbang,Woolery Joseph,Manley Thomas,Trümper Lorenz,Aboulafia David,Advani Ranjana,Alpdogan Onder,Ando Kiyoshi,Arcaini Luca,Baldini Luca,Bellam Naresh,Bartlett Nancy,Belada David,Yehuda Dina Ben,Benedetti Fabio,Borchman Peter,Bordessoule Dominique,Brice Pauline,Briones Javier,Caballero Dolores,Carella Angelo Michele,Chang Hung,Cheong June Weon,Cho Seok-Goo,Choi Ilseung,Choquet Sylvain,Colita Andrei,Congui Angela Giovanna,D'amore Francesco,Dang Nam,Davison Kelly,de Guibert Sophie,Brown Peter de Nully,Delwail Vincent,Demeter Judit,di Raimondo Francesco,Do Young Rok,Domingo Eva,Douvas Michael,Dreyling Martin,Ernst Thomas,Fanale Michelle,Fay Keith,Feldman Tatyana,Ferrero Silvia Fernandez,Flinn Ian Winchester,Forero-Torres Andres,Fox Christopher,Friedberg Jonathan,Fukuhara Noriko,Garcia-Marco Jose,Cruz Jorge Gayoso,Codina Jose Gomez,Gressin Remy,Grigg Andrew,Gurion Ronit,Christensen Jacob Haaber,Haioun Corinne,Hajek Roman,Hanel Mathias,Hatake Kiyohiko,Hensen Robert,Horowitz Netanel,Horwitz Steven,Huttmann Andreas,Illes Arpad,Illidge Tim,Ishizawa Kenichi,Islas-Ohlmayer Miguel,Jacobsen Eric,Janakiram Murali,Jurczak Wojciech,Kaminski Mark,Kato Koji,Kim Won Seog,Kirgner Ilya,Iyer Swaminathan,Kuo Ching-Yuan,Lazaroiu Mihaela Cornelia,Du Katell Le,Lee Jong-Seok,LeGouill Steven,Lennard Anne,LaRosee Paul,Levi Itai,Link Brian,Maisonneuve Herve,Maruyama Dai,Mayer Jiri,McCarty John,McKay Pam,Minami Yosuke,Mocikova Heidi,Morra Enrica,Morschhauser Franck,Munoz Javier,Nagai Hirokazu,O'Connor Owen,Opat Stephen,Pettengell Ruth,Pezzutto Antonio,Pfreundschuh Michael,Pluta Andrzej,Porcu PierLuigi,Pro Barbara,Quach Hang,Rambaldi Alessandro,Renwick William,Reyes Ruben,Izquierdo Antonia Rodriguez,Rossi Giuseppe,Ruan Jia,Rusconi Chiara,Salles Gilles,Santoro Armando,Sarriera Jose,Savage Kerry,Shibayama Hirohiko,Shustov Andrei,Suh Cheolwon,Sureda Anna,Tanimoto Mitsune,Taniwaki Masafumi,Tilly Herve,Tobinai Kensei,Trneny Marek,Trumper Lorenz,Tsukamoto Norifumi,Tsukasaki Kunihiro,Vitolo Umberto,Walewski Jan,Weidmann Eckhart,Wilhelm Martin,Witzens-Harig Mathias,Yacoub Abdulraheem,Yamamoto Kazuhito,Yeh Su-Peng,Yoon Sung-Soo,Yuen Sam,Yun Hwan Jung,Zain Jasmine,Zinzani Pier Luigi

Funder

National Institutes of Health National Cancer Institute Cancer Center

Publisher

Elsevier BV

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3